A potential COVID-19 EUA could turn this small biotech into a household name

Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. It’s not a done deal. But so far, all indications point to the probability of Veru, a small biotech, winning the latest Emergency Use Authorization from the FDA for a COVID-19 treatment. And if all goes well, … Read more

Biotech Spotlight: Graphite Bio seeks sickle cell cure with a next-gen approach

Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Welcome to Biotech Spotlight, a series featuring companies with breakthrough technologies and strategies. Today, we’re looking at Graphite Bio, a gene editing company advancing a treatment for sickle cell disease that makes use of precise methods of … Read more

Biotech Spotlight: Everest Medicines takes aim at unmet needs in Asia

Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Welcome to Biotech Spotlight, a series featuring companies with breakthrough technologies and strategies. Today, we’re looking at Everest Medicines, a late-stage clinical company, which is banking on partnerships and organic R&D to meet the unmet demands of … Read more

Two Pharma and Biotech Cases to Watch in 2022

“Based on the similarity of the questions presented to those that the Supreme Court declined to answer in Idenix v. Gilead, Amgen’s petition has a slim chance of success. Regardless, patent owners should be wary of asserting claims that characterize a monoclonal antibody purely on its function.” Monty Python and the Holy Grail: “I’m Not … Read more